IIT Madras-incubated QNu Labs has launched QShield 2.0, the platform behind its National Cryptographic Assessment & Assurance Framework, to help organisations inventory and assess cryptographic assets ahead of India's post-quantum transition.
Swiss AI-native automated optical inspection company Delvitech will set up a 65,000 sq ft manufacturing and technology facility in Bengaluru with an initial $10 million investment, rising to $25–30 million, and up to 800 jobs over five years.
Early-stage investor Lavni Ventures has closed its second deep-tech impact fund at its ₹200 crore target, with a ₹100 crore green-shoe option, to back foundational technologies in health and climate.
Pune-based Definedge has raised ₹22 crore in a Pre-Series A round, taking total funding to ₹30 crore, as it scales its trading platforms, launches an MCP interface for AI agents and targets ₹5,000 crore in AUM through Momentify.
PhonePe has secured in-principle approval from the Central Bank of the UAE for two payment licences, its first regulatory clearance outside India, as the Walmart-backed fintech plans to plug into local rails Aani and Jaywan.
Shanghai-based Jierendi Electronic Technology has raised approximately $13.8 million in Series B funding from SMIC Capital and GoodWe, positioning the company at the convergence of semiconductor manufacturing and AI-server power infrastructure.
Beijing-based semiconductor company Xingyun Integrated Circuit has raised close to $110 million in a late-stage financing round led by battery giant CATL, underscoring China's continued push toward self-sufficiency in power-related semiconductors.
London-based Metris Energy has raised €4.35 million in Seed funding to build an operating data layer for renewable-energy assets, allowing automation and AI systems to manage solar and wind portfolios more effectively.
UK fintech Sprive has raised $10 million in Series A funding to scale its platform that redirects everyday cashback spending toward mortgage overpayments, reporting more than 567,000 users and £42 billion in managed mortgages.
Belgian biotech Novadip Biosciences has closed €10.4 million in convertible financing to advance its regenerative bone therapy for a rare pediatric condition through pivotal Phase 3 trials in the US and Europe.